Cardiac Science Reports Q2 Revenue; Resumes AED...(activities 639 284 ...),Health

Date:8/10/2009

activities 639 284 --- --- Effect of exchange rate changes on cash and cash equivalents (27) - Net change in cash and cash equivalents 3,213 7,562 Cash and cash equivalents, beginning of period 34,655 20,159 Cash and cash equivalents, end of period $37,868 $27,721 ======= =======

                      Cardiac Science Corporation and Subsidiaries
               Reconciliation of GAAP Results to Non-GAAP Results (unaudited)
                                       (in thousands)


                                   Reconciliation of Net Income (Loss)
                                Attributable to Cardiac Science Corporation
                                             to Adjusted EBITDA


                                 Three Months Ended       Three Months Ended
                                    June 30, 2009           June 30, 2008
                                    -------------           -------------
                                               % of                  % of
                                             revenue               revenue
                                            --------               -------
     Net income (loss)
      attributable to Cardiac
      Science Corporation      $(2,106)        -5.8%     $2,286       4.4%
     Depreciation and
      amortization               1,542          4.3%      1,624       3.1%
     Interest income               (19)        -0.1%       (163)     -0.3%
     Income tax (benefit)
      expense                   (1,194)        -3.3%      1,407       2.7%
                                ------         ----       -----       ---
     EBITDA                     (1,777)        -4.9%     
'/>"/>
SOURCE  Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
Related medicine news :

1. Electronic Health Records Help Cardiac Patients Remain Healthy
2. Cooling treatment after cardiac arrest is cost-effective, Penn study shows
3. Harrison City ROCKS! Set for August 15, Music Festival to Benefit Cardiac Research at Childrens Hospital of Pittsburgh
4. Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent(TM) Portfolio License
5. Many Heart Attack Patients Not Referred to Cardiac Rehab  
6. Worlds First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial
7. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
8. Need for At-Home Blood Pressure Monitoring Underscored by High-Profile Cardiac Deaths
9. Cardiac CT is more cost effective when managing low-risk patients with chest pain
10. Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting
11. ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials